Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian markets trade in the red
Thu, 23 Jul 01:30 pm

Indian Indices are trading negative in the post noon trading session. Sectoral indices are trading on a mixed note with stocks from the steel and telecom sectors leading the losses.

The BSE-Sensex is trading down by 43 (down 0.2%) and the NSE-Nifty is trading down by 20 points (down 0.2%). The BSE Mid Cap index is trading marginally up while the BSE Small Cap index is trading up by 0.7%. Gold price, per 10 grams, is trading at Rs 24,845 level. Silver price, per kilogram, is trading at Rs 34,244 level. Crude oil is trading at Rs 3,162 per barrel. The rupee is trading at 63.66 to the US dollar.

Stocks in the automobile sector are trading mixed with Bajaj Auto and Eicher Motors leading the losses. As per a leading financial daily, Mahindra & Mahindra (M&M), India's largest utility maker, has launched a new version of its lifestyle off-road vehicle Thar. This version is priced at Rs 8.03 lakh ex-showroom and will be made available in only select markets. The company in order to improve its off road capability has also introduced mechanical locking rear differential technology. This technology engages automatically without driver's intervention. Thar is available in a BS IV variant with power steering as a standard fitment. Presently the stock of M&M is trading up by 1.4%.

Pharma stocks are trading on a mixed note with Divis Laboratories and Dr. Reddys Lab witnessing buying interest. According to financial times, Sun Pharma is in the process of integrating Ranbaxy, which it had acquired from Japan's Daiichi Sankyo earlier this year. It is also going to overhaul the combined global operations of the said company. This new plan is carried on to utilize the Paonta Sahib facility for supplies to the World Health Organization and other markets like Europe and Australia. Currently the stock of Sun Pharma is trading marginally down.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Indian markets trade in the red". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Jan 22, 2018 (Close)